Pharmaroth Labs Stock Performance
| ROTH Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pharmaroth Labs are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pharmaroth Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Pharmaroth Labs is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 5:1 | Last Split Date 2010-06-01 |
1 | I have no retirement savings My wife and I are in our 40s. She has an 85K Roth IRA. Is it too late for me | 10/09/2025 |
2 | Dont Want to Take Required Minimum Distributions Here Are 3 Ways to Get Out of Them. | 11/25/2025 |
3 | What is an IRA, and how does it work | 12/05/2025 |
4 | 12 Stocks That Dropped After Tax-Loss Sellingand Can Bounce Back - Barrons | 12/22/2025 |
Pharmaroth | Build AI portfolio with Pharmaroth Stock |
Pharmaroth Labs Relative Risk vs. Return Landscape
If you would invest 0.01 in Pharmaroth Labs on September 26, 2025 and sell it today you would earn a total of 0.00 from holding Pharmaroth Labs or generate 0.0% return on investment over 90 days. Pharmaroth Labs is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Pharmaroth, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pharmaroth Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmaroth Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharmaroth Labs, and traders can use it to determine the average amount a Pharmaroth Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ROTH |
Based on monthly moving average Pharmaroth Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmaroth Labs by adding Pharmaroth Labs to a well-diversified portfolio.
Pharmaroth Labs Fundamentals Growth
Pharmaroth Stock prices reflect investors' perceptions of the future prospects and financial health of Pharmaroth Labs, and Pharmaroth Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmaroth Stock performance.
| Profit Margin | (2.79) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 1.42 M | ||||
| Shares Outstanding | 149.35 M | ||||
| Price To Earning | (1.22) X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 181.56 K | ||||
| Gross Profit | 80.48 K | ||||
| Net Income | (91.52 K) | ||||
| Cash And Equivalents | 33 | ||||
| Total Debt | 853.53 K | ||||
| Current Ratio | 0.24 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (17.6 K) | ||||
| Market Capitalization | 14.94 K | ||||
| Total Asset | 304.05 K | ||||
| Retained Earnings | (2.89 M) | ||||
| Working Capital | (493 K) | ||||
| Current Asset | 207 K | ||||
| Current Liabilities | 700 K | ||||
About Pharmaroth Labs Performance
By evaluating Pharmaroth Labs' fundamental ratios, stakeholders can gain valuable insights into Pharmaroth Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmaroth Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmaroth Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 453.71 | 476.40 | |
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | 0.16 | 0.15 | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | 0.19 | 0.18 |
Things to note about Pharmaroth Labs performance evaluation
Checking the ongoing alerts about Pharmaroth Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharmaroth Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmaroth Labs generated a negative expected return over the last 90 days | |
| Pharmaroth Labs has some characteristics of a very speculative penny stock | |
| Pharmaroth Labs has a very high chance of going through financial distress in the upcoming years | |
| Pharmaroth Labs currently holds 853.53 K in liabilities. Pharmaroth Labs has a current ratio of 0.24, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmaroth Labs' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 181.56 K. Net Loss for the year was (91.52 K) with profit before overhead, payroll, taxes, and interest of 80.48 K. | |
| Pharmaroth Labs currently holds about 33 in cash with (17.6 K) of positive cash flow from operations. | |
| Pharmaroth Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: 12 Stocks That Dropped After Tax-Loss Sellingand Can Bounce Back - Barrons |
- Analyzing Pharmaroth Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmaroth Labs' stock is overvalued or undervalued compared to its peers.
- Examining Pharmaroth Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmaroth Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmaroth Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmaroth Labs' stock. These opinions can provide insight into Pharmaroth Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmaroth Stock analysis
When running Pharmaroth Labs' price analysis, check to measure Pharmaroth Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmaroth Labs is operating at the current time. Most of Pharmaroth Labs' value examination focuses on studying past and present price action to predict the probability of Pharmaroth Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmaroth Labs' price. Additionally, you may evaluate how the addition of Pharmaroth Labs to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |